|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Dimension Therapeutics, Inc. (DMTX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
25,044,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.95 - $5.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fmr Corp |
See Remark 1 |
– – – |
2017-11-07 |
4 |
D |
$6.00 |
$29,359,932 |
I/I |
(4,893,322) |
0 |
|
- |
|
| Wadsworth Samuel C. |
Chief Scientific Officer |
• – – |
2017-11-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(278,035) |
0 |
|
- |
|
| Clark K. Reed |
SVP of Pharmaceutical Develop |
• – – |
2016-06-07 |
4 |
AS |
$10.00 |
$50,000 |
D/D |
(5,000) |
0 |
|
- |
|
| Clark K. Reed |
SVP of Pharmaceutical Develop |
• – – |
2016-06-07 |
4 |
OE |
$0.38 |
$1,900 |
D/D |
5,000 |
5,000 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2016-05-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,106,784) |
4,893,322 |
|
- |
|
| Isaly Samuel D |
Director |
– • • |
2015-10-27 |
4 |
B |
$13.00 |
$2,600,000 |
I/I |
200,000 |
5,397,698 |
2.25 |
- |
|
| Isaly Samuel D |
Director |
– • • |
2015-10-27 |
4 |
A |
$0.00 |
$0 |
I/I |
5,197,698 |
5,197,698 |
|
- |
|
| Gupta Rishi |
Director |
– • • |
2015-10-27 |
4 |
B |
$13.00 |
$2,600,000 |
I/I |
200,000 |
5,397,698 |
2.25 |
- |
|
| Gupta Rishi |
Director |
– • • |
2015-10-27 |
4 |
A |
$0.00 |
$0 |
I/I |
5,197,698 |
5,197,698 |
|
- |
|
| Dybbs Michael |
Director |
– • – |
2015-10-27 |
4 |
B |
$13.00 |
$12,499,994 |
I/I |
961,538 |
2,059,283 |
2.1 |
- |
|
| Dybbs Michael |
Director |
– • – |
2015-10-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,097,745 |
1,097,745 |
|
- |
|
| Fmr Corp |
See Remark 1 |
– – • |
2015-10-27 |
4 |
A |
$0.00 |
$0 |
I/I |
6,760,627 |
7,000,106 |
|
- |
|
| Wadsworth Samuel C. |
Chief Scientific OfficerOffice |
• – – |
2015-10-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
278,035 |
|
- |
|
| Fmr Corp |
10% Owner |
– – • |
2015-10-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
239,479 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
